Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 3:S0002-9297(25)00320-9.
doi: 10.1016/j.ajhg.2025.08.010. Online ahead of print.

A clinical and genotype-phenotype analysis of MACF1 variants

Jordy Dekker  1 Rachel Schot  2 Kimberly A Aldinger  3 David B Everman  4 Camerun Washington  4 Julie R Jones  4 Jennifer A Sullivan  5 Rebecca C Spillmann  5 Vandana Shashi  5 Antonio Vitobello  6 Anne-Sophie Denommé-Pichon  6 Anne-Laure Mosca-Boidron  7 Laurence Perrin  8 Stéphane Auvin  9 Maha S Zaki  10 Joseph G Gleeson  11 Naomi Meave  11 Cassidy Wallace  11 Sophie Nambot  12 Julian Delanne  12 Sarah M Ruggiero  13 Ingo Helbig  13 Mark P Fitzgerald  13 Richard J Leventer  14 Dorothy K Grange  15 Emanuela Argilli  16 Elliott H Sherr  16 Supraja Prakash  17 Derek E Neilson  18 Francesco Nicita  19 Antonella Sferra  19 Enrico S Bertini  19 Chiara Aiello  20 Knut Brockmann  21 Alexander B Kuranov  22 Silke Kaulfuss  22 Sulman Basit  23 Majed Alluqmani  24 Ahmad Almatrafi  25 Jan M Friedman  26 Colleen Guimond  26 Faruq Mohammed  27 Pooja Sharma  27 Divya Goel  28 Thomas Wirth  29 Mathieu Anheim  30 Paulina Bahena  31 Asuman Koparir  31 Konstantinos Kolokotronis  31 Barbara Vona  32 Thomas Haaf  31 Erdmute Kunstmann  31 Reza Maroofian  33 Henrike L Sczakiel  34 Felix Boschann  35 Mala Misra-Isrie  36 Raymond J Louie  4 Elliot S Stolerman  4 Pedro A Sanchez-Lara  37 Sandra Mergler  38 Renske Oegema  39 Yuri A Zarate  40 Ariana Kariminejad  41 Homa Tajsharghi  42 Shimriet Zeidler  43 Anneke J A Kievit  43 Arjan Bouman  43 Gerarda Cappuccio  44 Nicola Brunetti-Pierri  45 Kyra E Stuurman  43 Dayna Morel Swols  46 Mustafa Tekin  46 Jariya Upadia  47 Donna M Martin  48 Daniel Craven  49 Susan M Hiatt  50 Laura A van de Pol  51 Felice D'Arco  52 Henri Margot  53 Martina Wilke  43 Soheil Yousefi  43 Tahsin Stefan Barakat  2 Monique M van Veghel-Plandsoen  43 Eleonora Aronica  54 Jasper Anink  55 Stephen L Rogers  56 Kevin C Slep  57 Dan Doherty  58 William B Dobyns  59 Grazia M S Mancini  43
Affiliations

A clinical and genotype-phenotype analysis of MACF1 variants

Jordy Dekker et al. Am J Hum Genet. .

Abstract

Microtubule-actin cross-linking factor 1 (MACF1) is a large protein of the spectraplakin family, which is essential for brain development. MACF1 interacts with microtubules through the growth arrest-specific 2 (Gas2)-related (GAR) domain. Heterozygous MACF1 missense variants affecting the zinc-binding residues in this domain result in a distinctive cortical and brain stem malformation. Evidence for other MACF1-associated disorders is still limited. Here, we present a cohort of 45 individuals with heterozygous or bi-allelic MACF1 variants to explore the phenotypic spectrum and assess possible pathogenic relevance. We observe that de novo heterozygous missense variants in the EF-hand domains also result in distinctive brain malformation and provide experimental evidence that variants in the EF-hand/GAR module increase microtubule binding, suggestive of a toxic gain of function. Notably, no phenotype-genotype correlation was possible for the remaining heterozygous variants in other domains. A clinical review of eight families with bi-allelic variants reveals a possible complex neurodevelopmental syndrome of the central and peripheral nervous systems. In these individuals, bi-allelic variants mostly affect the Plakin domain. Furthermore, RNA sequencing and chromatin immunoprecipitation (ChIP) analyses of human fetal brain tissue reveal five MACF1 isoforms with region-specific expression, differing in their exon 1 transcription start sites but splicing to a common exon 2. This differential expression explains the frontal-predominant lissencephaly in an individual with a homozygous stop-gain in exon 1 (MACF1-204: c.70C>T [p.Arg24∗]), as this isoform is preferentially expressed in the frontal cortex. We conclude that MACF1-related disorders are strictly linked to domain function and the level of transcript expression, explaining the observed wide clinical heterogeneity.

Keywords: ACF7; MACF1; axonal pathfinding; brainstem hypoplasia; lissencephaly; microtubules.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, and Katz SI (1981). Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24, 897–903. - PubMed
    1. Byers TJ, Beggs AH, McNally EM, and Kunkel LM (1995). Novel actin crosslinker superfamily member identified by a two step degenerate PCR procedure. FEBS Lett 368, 500–504. - PubMed
    1. Yang Y, Dowling J, Yu QC, Kouklis P, Cleveland DW, and Fuchs E (1996). An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 86, 655–665. - PubMed
    1. Leung CL, Sun D, Zheng M, Knowles DR, and Liem RK (1999). Microtubule actin cross-linking factor (MACF): a hybrid of dystonin and dystrophin that can interact with the actin and microtubule cytoskeletons. J Cell Biol 147, 1275–1286. - PMC - PubMed
    1. Feng Y, and Walsh CA (2001). Protein-protein interactions, cytoskeletal regulation and neuronal migration. Nat Rev Neurosci 2, 408–416. - PubMed

LinkOut - more resources